newsfilter
← Latest News
GlobeNewswire·

NexImmune Announces Publication in Frontiers in Medicine Highlighting the Company's AIM Platform to Treat Viral Diseases

AIM technology represents a scalable therapeutic platform that has the potential to create new, multi-antigen specific therapies for virally driven infectious diseases, cancers and autoimmune diseases GAITHERSBURG,